Hormonal Regulation (Lecture 34) Flashcards
Genetic Evidence of the importance of TFs
There are diseases linked to mutations in transcription factors (TFs) proving their importance.
ex/ Form of diabetes - MODY (maturity onset diabetes of the young
By looking at the mutations one can learn the mechanism of action of TFs
centra zone
The central zone is the zone of convergence of the DBD, LBD and the hinge region in one location. The receptors use this zone to communicate with each other (such as a domain effect when a ligand binds).
explain the activity of NR HNF-4 alpha
PRMT1 (methyl transferase) is a coactivator of HNF-4𝛼 , it adds a methyl residue of an Arginine residue (R91). This solidifies the interaction between all of the units. In the diagram it touches the LBD of both subunits which helps the dimer to form and interact with DNA. This is how a coactivator can solidify the act of one transcription factor. = ‘Accelerator’
The ‘break’ is the phosphorylation of residue S78 of the LBD of one subunit in the same region by PKC (protein Kinase C) which creates a clash with Y319 of the other subunit’s LBD. Diagram C = it interferes with the connection of the two subunits and leads to loss of dimerization and loss of DNA binding.
Thus, even if the amino acids come from far away, they integrate into a single domain which is important for the function of the receptors. Even though the receptor is linear, the protein is not. The folded structure creates the convergence zone to help the reaction of the receptor.
MODY Mutation
There are many mutations in the LBD, which causes interference with ligand binding
It is unusual that the majority of mutations are in the hinge region. These mutations cause
hyperinsulinemic hypoglycemia.
The mutation in the hinge region is in R127W and D126Y which missaligns the two DBDs
(DNA binding domain) and prevents a good interaction with AGGTCA half-site
Another set of mutations in 1314F and R324H, which fold back near the hinge region, reduce the
activity of the region and the receptor.
The wild type receptor functions well, but the mutations reduce the receptor activity, leading to
the MODY disease. Complete knockdown of the receptor HNF-4𝛼 results in death.
This is a disease that demonstrates the significance of transcription in metabolic control.
NR control of Bile Acids is controlled by which receptor
FXR
Bile Acids
Bile acids are storage acids that form micelles that help with the transport and absorption
of lipids. They are synthesized from cholesterol in the liver and circulate in the intestine. The lipids are brought back to the liver to be distributed or further metabolized. They cannot diffuse through membranes freely and require a transporter.
how are bile acids synthesized?
BAs are made from cholesterol in a series of oxidation reactions.
The rate limiting enzyme is CYP7A1, which is in the first step of metabolizing cholesterol to
7α-hydroxycholesterol. 7α-hydroxycholesterol goes on to a neutral pathway to produce colic acid (the main BA) and CDCA.
These are terminal metabolites that are conjugated with Glycine or Taurine. The BAs cannot cross membranes because they are hydrophobic and hydrophilic. They must form micelles to be able to be transported.
7α-hydroxycholesterol is the ligand for nuclear receptor LXR.
FXR is a nuclear receptor that is the BA intracellular sensor: When BA levels are high, FXR
represses their synthesis.
FXR ligands
CDCA and cholic acid
removal of FXR in mice causes:
high levels of BA, cholesterol, Triglycerides and fatty liver as well as cardiovascular diseases arise form this
FXR working in the intestines
The intestine has BAs which activate FXR that produces the growth factor FGF15.
FXR working in the liver
The liver BAs activate FXR which activates another nuclear receptor called SHP, which through signaling through FGF15 inhibits the expression of CYP7A1 (rate limiting step in Bile Acid synthesis)
what is the mechanism for FXR when BA are high
FXR does not directly control CYP7A1 expression
FXR forms a heterodimer with RXR. In the liver when CDCA activates FXR, FXR induces the expression of SHP. Then SHP works with nuclear receptor LRH, and this complex acquires corepressors to express the repression of Asbt and CYP7A1.
Asbt is the major BA transport system in enterocytes. Asbt deficiency causes major BA absorption disease.
FXR is the BA sensor which reacts to a high or low level of BAs to control their synthesis and transport
what is the mechanism for FXR when BA are high
SHP and FGF15 are not expressed. LRH forms a heterodimer with RXR instead of SHP, and LRH-RXR complex works with coactivators to induce the expression of CYP7A1 and Asbt.
effects of fructose on humans
giving fructose directly to humans increases
intra-abdominal adipose mass. This diet also increases postprandial plasma triglyceride (TG) concentrations because of a rapid increase in de novo lipogenesis because of the generation of triose phosphates (GA3P).
what biochemical pathways is initiated by fructose, and how does this occur?
Ingesting fructose leads to lipid synthesis because of the increase
of lipogenic precursors.
Enzymes that are crucial for the synthesis of lipids are under the
control of the lipogenic precursors SREBP 1c, ChREBP which works with PGC-1β. They induce the other enzymes to increase lipogenesis in response to fructose.
The molecular pathway of upregulating the lipogenic enzymes by SREBP 1c, ChREBP, PGC-1β is unknown.